INS and type 2 diabetes mellitus: In a study in newly diagnosed patients with T2DM, patients treated with an SU for up to 6 years showed a lower C-peptide response to glucagon than patients treated with insulin, suggesting a more rapid deterioration in beta-cell function and endogenous insulin production [10-12].